Back to List View Graph View

Diabetic nephropathy

Diabetic nephropathy, also called diabetic kidney disease, is a diabetes-associated disorder of renal structure and function.

Where the papers sit

9 papers from the last 6 months study diabetic nephropathy directly · updated from PubMed 2 Nov 2026

Study type 0 clinical trials · 5 observational · 1 human data · 3 preclinical

Themes one subject

Those 9 are all about one subject.

  • Diabetes-Related Kidney Disease

    Risk assessment spans uric acid-to-HDL, neutrophil-to-HDL, lactate, frailty, and other clinical markers, with observational and Mendelian-randomization evidence still exploratory. Mechanistic studies converge on inflammation, macrophage infiltration, podocyte injury, antiglycation effects, fibrosis, ferroptosis, and JAK/STAT signaling. Kidney biopsy work is refining diagnosis by challenging nonspecific diabetic labels. Overall, the field remains broad and early, linking risk stratification with targeted protection of renal cells.

    9 papers

Papers

The 9 papers from the last 6 months that study diabetic nephropathy directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Diabetes-Related Kidney Disease (9)
  1. Association between the uric acid to high-density lipoprotein cholesterol ratio and diabetic kidney disease in U.S. adults with type 2 diabetes: A cross-sectional study of NHANES 2009 to 2018. Medicine · 17 Oct 2026 PMID 42888531
  2. A standardized fraction of Cajanus scarabaeoides attenuates diabetic nephropathy via antiglycation, anti-inflammatory, and anti-fibrotic mechanisms. Journal of natural medicines · 4 Oct 2026 PMID 42830373
  3. GABA ameliorates diabetic kidney disease-induced podocyte injury via JAML-FPR2 axis-mediated suppression of macrophage infiltration. Renal failure · 1 Oct 2026 PMID 42820494
  4. Associations between serum lactate and renal dysfunction in diabetic kidney disease: An exploratory analysis integrating animal experiments, clinical cohorts, and bioinformatic approaches. PloS one · 15 Sept 2026 PMID 42743268
  5. Mislabeling No More: What Kidney Biopsies Reveal in Diabetes. Journal of nephrology · 24 Aug 2026 PMID 42634195
  6. Association between neutrophil-to-HDL cholesterol ratio and diabetic nephropathy in adults with diabetes mellitus: A cross-sectional study from NHANES 2007-2018. Medicine · 15 Aug 2026 PMID 42601692
  7. Construction and validation of a machine learning-based risk prediction model for venous thromboembolism in older adult patients: A multifactorial analysis of 28,231 cases. Medicine · 18 Jul 2026 PMID 42470007
  8. Peimisine ameliorates diabetic nephropathy by attenuating inflammation and ferroptosis through inhibition of the JAK/STAT pathway. Experimental cell research · 10 Jul 2026 PMID 42431389
  9. Frailty index and type 2 diabetes with renal complications: insights from Mendelian randomization and retrospective observational study. Renal failure · 23 Jun 2026 PMID 42336394

By study type

Observational studies and case reports (5)
  1. Association between the uric acid to high-density lipoprotein cholesterol ratio and diabetic kidney disease in U.S. adults with type 2 diabetes: A cross-sectional study of NHANES 2009 to 2018. Medicine · 17 Oct 2026 PMID 42888531
  2. Associations between serum lactate and renal dysfunction in diabetic kidney disease: An exploratory analysis integrating animal experiments, clinical cohorts, and bioinformatic approaches. PloS one · 15 Sept 2026 PMID 42743268
  3. Mislabeling No More: What Kidney Biopsies Reveal in Diabetes. Journal of nephrology · 24 Aug 2026 PMID 42634195
  4. Association between neutrophil-to-HDL cholesterol ratio and diabetic nephropathy in adults with diabetes mellitus: A cross-sectional study from NHANES 2007-2018. Medicine · 15 Aug 2026 PMID 42601692
  5. Frailty index and type 2 diabetes with renal complications: insights from Mendelian randomization and retrospective observational study. Renal failure · 23 Jun 2026 PMID 42336394
Human data, design not indexed (1)
  1. Construction and validation of a machine learning-based risk prediction model for venous thromboembolism in older adult patients: A multifactorial analysis of 28,231 cases. Medicine · 18 Jul 2026 PMID 42470007
Preclinical: animal, cell and lab studies (3)
  1. A standardized fraction of Cajanus scarabaeoides attenuates diabetic nephropathy via antiglycation, anti-inflammatory, and anti-fibrotic mechanisms. Journal of natural medicines · 4 Oct 2026 PMID 42830373
  2. GABA ameliorates diabetic kidney disease-induced podocyte injury via JAML-FPR2 axis-mediated suppression of macrophage infiltration. Renal failure · 1 Oct 2026 PMID 42820494
  3. Peimisine ameliorates diabetic nephropathy by attenuating inflammation and ferroptosis through inhibition of the JAK/STAT pathway. Experimental cell research · 10 Jul 2026 PMID 42431389